Cargando…
Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors
Somatostatin receptors (SSTR) are commonly expressed by neuroendocrine tumors. Expression of SSTR-2a and SSTR-5 may impact symptomatic management; however, the impact on survival is unclear. The aim of this study is to correlate SSTR-2a and SSTR-5 expression in pancreatic neuroendocrine tumors (PNET...
Autores principales: | Mehta, Shreya, de Reuver, Philip R., Gill, Preetjote, Andrici, Juliana, D’Urso, Lisa, Mittal, Anubhav, Pavlakis, Nick, Clarke, Stephen, Samra, Jaswinder S., Gill, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616753/ https://www.ncbi.nlm.nih.gov/pubmed/26447992 http://dx.doi.org/10.1097/MD.0000000000001281 |
Ejemplares similares
-
The prognostic role of Ki-67/MIB-1 in meningioma: A systematic review with meta-analysis
por: Liu, Ning, et al.
Publicado: (2020) -
Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis
por: Stephenson, David, et al.
Publicado: (2017) -
mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer
por: Shahbaz, Muhammad, et al.
Publicado: (2015) -
Expression of Somatostatin Receptor Subtypes (SSTR-1–SSTR-5) in Pediatric Hematological and Oncological Disorders
por: Harda, Kristof, et al.
Publicado: (2020) -
Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
por: Wu, Wei, et al.
Publicado: (2020)